Elaina Sexton, MD, MSc Obstetrics and Gynecology St. Vincent s Hospital. Objectives
|
|
- Bernadette Brown
- 5 years ago
- Views:
Transcription
1 Elaina Sexton, MD, MSc Obstetrics and Gynecology St. Vincent s Hospital Objectives Definition of normal menstrual cycle and abnormal uterine bleeding (AUB) Evaluation of AUB Medical options for AUB Surgical options for AUB 1
2 Normal Menstrual Cycle Interval 28 +/- 7 days (21-35) Duration Quantity Onset Age of Menopause Mean loss of iron/cycle 70% of blood loss 4 +/- 2 days (2-6) 40 cc +/- 20 cc (<80cc) 11 to 13 years 51 years 13 mg In first 2 days Hypothalamus Pituitary Ovary Uterus 2
3 Abnormal Uterine Bleeding Definitions Polymenorrhea: cycles < 21 days Oligomenorrhea: cycles > 35 days Menorrhagia: >80 cc of blood loss >7 days of bleeding Bleeding sufficient to cause anemia Hypomenorrha: <2 days of bleeding Metrorrhagia/Intermenstrual bleeding: bleeding at any other time than during the normal period Abnormal Uterine Bleeding Categories Pregnancy related Anovulatory Hormonal Ovulatory Anatomical Categories Estrogen breakthrough Too much Progestin breakthough Atrophic Estrogen withdrawal Atrophic Progestin withdrawal Normal response 3
4 Endometrial Development Estrogen Causes endometrial proliferation days 3 to 14 menstrual cycle From < 5 mm to 8 15 mm (total thickness) Progesterone Limits further endometrial growth (stabilizes) Induces: Secretory transformation Stromal edema Pseudo-decidualization Endometrial Development Endometrial Layers Functionalis: upper two thirds Proliferative, secretory and menstrual component Stratum spongiosum: edematous stroma with spiral arteries Stratum compactum: superficial layer Basalis: lower one third Regenerative layer Contains basal arteries from which spiral arteries grow 4
5 A Normal Period Progesterone Withdrawal After secretory withdrawal, progesterone withdrawal induces organized sloughing of functionalis layer down to the basalis layer Spiral and basal artery vasoconstriction and myometrial contraction limit bleeding Thrombin platelet plugs form Estrogen Rising estrogen levels cover up denuded basalislayer with new functionalis endometrium limiting bleeding Anovulatory Bleeding Estrogen breakthrough Growing follicle makes estradiol (E2) E2 thickens endometrium (can measure with ultrasound) No luteal progesterone to stabilize endometrium No progestin withdrawal to allow organized sloughing Endometrium outgrows blood supply and random segments detach at random intervals No spiral artery constriction so bleeding can be heavy Increased risk of hyperplasia/ca due to unopposed E2 5
6 Progestin Breakthrough Excess progestin causes thin, denuded friable endometrium that bleeds (need ultrasound) Frequent problem on OCPs and Depo provera Treatment is NOT to give more progestin! Switching to higher estrogen pill or adding exogenous estrogen works well Double dosing OCPs not effective (too much progestin) Systemic Diseases Ovulatory Bleeding Blood dyscrasias: Von Willebrand s(vwf) disease: most common dyscrasiain adolescents with uncontrolled bleeding Dx: vwf level, bleeding time Treat with desmopressin (DDAVP) or Factor VIII Factor deficiencies ITP Leukemia Endocrine Hypothyroidism (check TSH, prolactin) 6
7 Ovulatory Bleeding Anatomic Abnormalities GYN malignancies: cervix, endometrial, vagina, vulvar Leiomyomas Polyps Adenomyosis Infections, trauma, foreign bodies, urethral prolapse Blood tests Work up of AUB hcg: First test, ALWAYS, ALWAYS!!! TSH, Prolactin, Androgens CBC, iron, and coagulation studies, bleeding time, vwf, factor VIII Imaging: Ultrasound (sensitivity = 75%) Fibroids,polyps, adenomyosis EMT < 5mm reassuring for low risk of hyperplasia (post menopausal) Hysteroscopy 7
8 Endometrial Biopsy When to Biopsy? Age 35 years to menopause Any abnormal uterine bleeding Prolonged Younger than 35 Persistent AUB Bleeding in the setting of unopposed estrogen (obesity, chronic anovulation) Tamoxifen Lynch Syndrome Treatment Anovulatory Bleeding Cyclic Progestins OCPs Depo Provera GnRH Agonist Ovulatory Bleeding NSAIDs Antifibrinolytics Progestin IUD Reduction of Bleeding 30% 50% 60% 90% 20-50% 50% 80-90% 8
9 Medical Therapy- OCPs First approved for use for contraception in the United States in 1960 Used by more than 100 women worldwide Used by 12 million women in the US Less than 1% of women in Japan use the pill while more than 1/3 of women in the UK use the pill 9
10 OCPs Inhibit follicular development and prevent ovulation Progesterone negative feedback decreases the release of GnRH by hypothalamus which decreases the release of FSH and LH Decreased FSH inhibits follicular development which leads to decreased levels of estradiol and lack of an LH surge which prevents ovulation Cervical mucus is thickened to inhibit sperm penetration Estrogen Better cycle control OCPs Reduction in breakthrough bleeding Stabilize endometrium Negative feedback on anterior pituitary inhibits secretion of FSH Helps prevents ovulation and inhibits follicular development 10
11 Contraindications: Smokers over age 35 Migraine with aura OCPs Known or suspected breast cancer Liver disease (cirrhosis) or liver tumor Blood clotting disorders Cardiovascular disease OCPs Advantages: Cheap Improvement in dysmenorrhea, ovarian cysts, acne, endometriosis, and PCOS Decreases risk of ovarian cancer, endometrial cancer and colorectal cancer Decreases anemia due to menorrhagia Increased risk of DVT Pregnancy rate 2 to 8% because of skipping pills 11
12 Medical Therapy- DMPA Inhibits follicular development and prevents ovulation Decreases the pulse frequency GnRH by the hypothalmauswhich decreases the release of FSH and LH by the anterior pituitary Decreased levels of FSH prevent follicular development and therefore prevent an increase in estradiol levels Lack of estrogen positive feedback prevents LH surge Lack of LH surge prevents ovulation Advantages: DMPA Highly effective contraception Injection every 12 weeks NO estrogen so decreased risk of DVTs, stroke, and endometrial cancer Decreased incidence of primary dysmenorrhea, ovulation pain and ovarian cysts 12
13 DMPA Disadvantages: IM injection Irregular bleeding Progestin related side effects Alopecia Bone Loss Weight Gain Medical Therapy Cyclic Progestins Works as a medical curettage Medroxyprogesterone 10 mg PO q daily for 5 to 7 days Excellent for mid cycle bleeding, or when EMB demonstrates proliferative endometrium Must rule out atypiaor endometrial cancer before using 13
14 Cyclic Progestins Advantages: Helps with most mild bleeding Can be used in post menopausal women Progestin related side effects Does NOT work in acute bleeding Medical Therapy GnRH Agonist Synthetic peptide modeled after hypothalamus neurohormone GnRH Interacts with the GnRH receptor Works by initially increasing the release of gonadotropins followed by densensitizationand downregulation Leads to a hypogonadotropic state which resembles menopause Highly effective treatment for AUB Most women develop amenorrhea 14
15 Disadvantages: GnRH Agonists Rapid resumption of menses following discontinuation of medication Side effects include hot flashes, vaginal dryness, sleep disturbances, and mood swings Bone loss is the most serious side effect and limits therapy GnRH Agonists Commonly used as preoperative treatment for leiomyomas Can use add back therapy, estrogen mg and progesterone 2.5 mg in order to minimize the hypoestrogenic side effects 15
16 Medical Therapy- Antifibrinolytics Reduced menstrual flow 30 to 55% from baseline Approved in 2009 Inhibits multiple plasminogen binding sites, decreasing plasmin formation and fibrinolysis More effective than NSAIDs Less effective than IUD Only take during menses Contraindicated in women at risk for thrombosis Medical Therapy- NSAIDs Reduced volume of menstrual blood loss by 20 to 50% Mechanism of action is a reduction in the production of prostanglandinsynthesis in the endometrium which leads to vasoconstriction and reduced bleeding Less effective than IUD Several options including naproxen, ibuprofen, mefenamicacid 16
17 NSAIDs Advantages Cheap Reduction in dysmenorrhea Taken during menses only Disadvantages GI side effects including bleeding, ulcer Medical Therapy- Progestin IUD Reduces menstrual blood loss by 74 to 97% after one year of use (Mirena) Can be used by women with thrombophilia disorders FDA approved in 2009 for menorrhagia High local progestin concentration results in thinning of the endometrium Most effective medical treatment for menorrhagia 17
18 Progestin IUD Two doses available One contains 52mg of levonorgestrel with an intial release of 20 mcg/day (Mirena) Other contains 13.5 mg of levonorgestrelwith an initial release of 14 mcg/day (Skyla) Mirena IUD Progestin effect is mainly local Endometrial concentration of levonorgestrel is 1000 times higher than that obeserved with the subdermal implant Plasma concentration much lower Plasma concentration is enough to suppress ovulation in some patients 18
19 Mirena IUD Contraindications Uterine distortion anomalies, fibroids Active pelvic infection Known or suspected pregnancy Unexplained abnormal uterine bleeding Current breast cancer Menstrual Blood Loss in IUD Users Study Group Mean Blood Loss (ml) Control Copper T LNG-IUD 35 5o
20 Severe bleeding Estrogen If hemodynamicallystable, first line therapy is high dose oral estrogen, Premarin 2.5 mg four times daily An alternative regimen is high dose oral contraceptives (containing 30 to 35 mcg ethinylestradiol) taken two to four times daily Severe bleeding related to anovulation can be treated with high dose progestins (thickened endometrium) Medical Therapy Attributes NSAIDs OCs DMPA LNG-IUD Efficacy 20 to 25% 50% 60% 90% Dosing Changein Bleeding Pattern 3 x daily during menses Modest blood loss Daily 3 months 5 years Modest blood loss Reduction in blood loss to amenorrhea Reduction in bloodloss to amenorrhea Side Effects GI Hormonally related Contraceptive Effects 1 year pregnancy rate None Moderatelyto highly effective Hormonally related Highly effective Occasional hormonal Highly effective N/A 5% 0.3% 0.1% 20
21 Uterine Artery Embolization Indicated for premenopausal women with symptoms related to fibroids who wish to retain their uterus, avoid prolonged medical therapy and avoid surgery Performed under local anesthesia Catheter passed into distal portion of one of the uterine arteries under fluroscopicguidance followed by infusion of the embolizing agent Long term outcomes show reduction of 85 to 95% in bleeding Uterine Artery Embolization Performed by interventional radiologists Not recommended for patients who desire future fertility 2% complication rates (including deaths from infections due to infarcting, degenerating fibroids) 80 to 90% success rate 21
22 Uterine Artery Embolization Surgical Treatments Hysteroscopy Myomectomy Hysterectomy Endometrial Ablation 22
23 Hysteroscopic Myomectomy Performed for intracavitary fibroids Indications: AUB Recurrent pregnancy loss Infertility Dysmenorrhea Fibroids should be less than 3 cm in size Patients with multiple fibroids are not likely to benefit from this procedure Success rate 75 to 90% Hysteroscopic Resection 23
24 Endometrial Ablation Surgical destruction of the endometrial lining Technologies approved in the United States: Bipolar radiofrequency (Novasure) Hot liquid filled balloon (Thermachoice) Cryotherapy(Her Option) Circulation Hot Water (Hydro Thermaablation) Microwave (Microwave Endometrial Ablation) Endometrial Ablation Contraindications: Desire to preserve fertility Endometrial hyperplasia or cancer Uterine anomalies Myometrial thinning following uterine surgery Postmenopausal women Active pelvic infection Presence of fibroids controversial 24
25 Endometrial Ablation- Novasure Three dimensional bipolar mesh that delivers radiofrequency current Advantages: Reduction in uterine bleeding very high at 5 years (98%) Low rates of hysterectomy following procedure Disadvantage: Cannot be used in women with irregular shaped uterine cavities Endometrial Ablation- Hydro ThermalAblator Hysteroscopicsheath is inserted into the uterine cavity under direct visualization Heated isotonic saline is administered through the sheath Advantages: Can be used in women with intracavitary lesions Done under direct visualization Disadvantages: Postoperative pain higher Reports of vaginal and perineal burns 25
26 Hysterectomy Most commonly performed gynecological procedure Prevalence decreasing due to availability of less invasive therapies Methods: Abdominal Vaginal Laparoscopic Robotic Assisted Hysterectomy Cochrane Review 2006, Review of 3 approaches to hysterectomy for benign gynecological disease Laparoscopic hysterectomy compared to Abdominal Hysterectomy Shorter hospitalization Quicker return to normal activities Fewer infections Less blood loss Longer operating time More urinary tract injuries 26
27 Hysterectomy Vaginal hysterectomy compared to Abdominal hysterectomy Shorter hospitalization Quicker return to normal activities Fewer infections Laparoscopic hysterctomycompared to vaginal hysterectomy Similar outcomes Robotic Assisted Advantages: Superior 3D visual input Hysterectomy Minimally invasive approach for procedures that would otherwise require laparotomy Mechanical freedom Shorter hospital stay More rapid post operative recovery Ability to operate in obese patients 27
28 Hysterectomy Robotic Assisted Disadvantages: COST Increased operating room time Steep learning curve for the surgeon Lack of tactile feedback Conclusions Abnormal uterine bleeding can have many different etiologies including hormonal or structural Careful evaluation of the cause should be performed including physical exam, labs and imaging studies Many different treatment options, both medical and surgical to fit the patient s needs 28
29 Questions?? 29
Frequency of menses. Duration of menses 3 days to 7 days. Flow/amount of menses Average blood loss with menstruation is 60-80cc.
Frequency of menses 24 days (0.5%) to 35 days (0.9%) Age 25, 40% are between 25 and 28 days Age 25-35, 60% are between 25 and 28 days Teens and women over 40 s cycles may be longer apart Duration of menses
More informationConflicts 10/5/2016. Abnormal Uterine Bleeding. Objectives Review diagnosis and updated nomenclature. Management options for acute and chronic AUB.
Abnormal Uterine Bleeding Barbara L. Keller, MD JD Naval Hospital Oak Harbor OB/GYN Physician Conflicts I have no conflicts or financial interests to disclose. Objectives Review diagnosis and updated nomenclature.
More informationAbnormal Uterine Bleeding Case Studies
Case Study 1 Abnormal Uterine Bleeding Case Studies Abigail, a 24 year old female, presents to your office complaining that her menstrual cycles have become a problem. They are now lasting 6 7 days instead
More informationManagement of Abnormal Uterine Bleeding. Julie Strickland MD, MPH University of Missouri Kansas City Department of Obstetrics and Gynecology
Management of Abnormal Uterine Bleeding Julie Strickland MD, MPH University of Missouri Kansas City Department of Obstetrics and Gynecology AUB Abnormal uterine bleeding (AUB): fairly broad term referring
More information5/5/2010 FINANCIAL DISCLOSURE. Abnormal Uterine Bleeding. Is This A Problem? About me % of visits to gynecologist
Abnormal Uterine FINANCIAL DISCLOSURE I HAVE NO FINANCIAL INTEREST IN ANY OF THE PRODUCTS MENTIONED IN MY PRESENTATION Bryan K. Rone, M.D. University of Kentucky Obstetrics and Gynecology May 5, 2010 About
More informationDr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre
Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre AUB Outline Terminology Classification/Etiology Assessment Treatment Referral to Gynaecology U c pt 4
More informationCynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital
Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital Touchdown to CME Eighth District Academy of Osteopathic Medicine & Surgery October 8. 2017 Goals
More informationDysfunctional Uterine Bleeding (DUB) OB/GYN Hospital of Fudan University Weiwei Feng, MD,Ph D Tel:
Dysfunctional Uterine Bleeding (DUB) OB/GYN Hospital of Fudan University Weiwei Feng, MD,Ph D Email: wfeng7347@aliyun.com Tel: 13918551061 2014-8-20 Contents DUB: definition, mechanism of normal menses,
More informationPALM-COEIN: Your AUB Counseling Guide
PALM-COEIN: Your AUB Counseling Guide 10 million+ Treat the cause, not the symptom In the U.S, more than 10 million women between the ages of 35 and 49 are affected by AUB 1 Diagnosis Cause Structural
More informationGynecologic Decision Making Based on Sonographic Findings
Gynecologic Decision Making Based on Sonographic Findings Mindy Goldman, MD Department of Obstetrics & Gynecology & Vickie A. Feldstein, MD Department of Radiology University of California, San Francisco
More informationMenstrual Disorders & Ambulatory Gynaecology
Menstrual Disorders & Ambulatory Gynaecology Mr. Nagui Lewis Aziz M B, CH B, FRCOG Consultant Gynaecologist The Royal Oldham Hospital 01/09/2018 Heavy menstrual bleeding (HMB ) is a common problem responsible
More informationReproductive Health and Pituitary Disease
Reproductive Health and Pituitary Disease Janet F. McLaren, MD Assistant Professor Division of Reproductive Endocrinology and Infertility Department of Obstetrics and Gynecology jmclaren@uabmc.edu Objectives
More informationAbnormal Uterine Bleeding: Evaluation of Premenopausal Women. Vanessa Jacoby, MD, MAS Assistant Professor Ob, Gyn, & Reproductive Sciences UCSF
Abnormal Uterine Bleeding: Evaluation of Premenopausal Women Vanessa Jacoby, MD, MAS Assistant Professor Ob, Gyn, & Reproductive Sciences UCSF Objectives Define normal and abnormal uterine bleeding Review
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal myomectomy in leiomyoma management, 77 Abnormal uterine bleeding (AUB) described, 103 105 normal menstrual bleeding vs., 104
More informationCLEAR COVERAGE HYSTERECTOMY CHECKLISTS
CLEAR COVERAGE HYSTERECTOMY CHECKLISTS Click on the link below to access the checklist sheet. Abnormal Uterine Bleeding Adenomyosis Chronic Abdominal or Pelvic Pain Endometriosis Fibroids General Guidelines
More informationHormonal Control of Human Reproduction
Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with
More informationChapter 100 Gynecologic Disorders
Chapter 100 Gynecologic Disorders Episode Overview: 1. Describe the presentation and RF for Adnexal torsion 2. List the imaging findings of adnexal torsion (US vs CT) 3. What is the management of adnexal
More informationWhat s New in Adolescent Contraception?
What s New in Adolescent Contraception? Abby Furukawa, MD Legacy Medical Group Portland Obstetrics and Gynecology April 29, 2017 Objectives Provide an update on contraception options for the adolescent
More information1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH.
1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH. 2. This causes the anterior pituitary to secrete small quantities of FSH and LH. 3. At this time, the follicles in the
More informationReproductive System. Testes. Accessory reproductive organs. gametogenesis hormones. Reproductive tract & Glands
Reproductive System Testes gametogenesis hormones Accessory reproductive organs Reproductive tract & Glands transport gametes provide nourishment for gametes Hormonal regulation in men Hypothalamus - puberty
More informationExcessive menstrual blood loss
Ian Chilcott Excessive menstrual blood loss >80mls - That interferes with physical, emotional, social and material quality of life 1 in 20 women aged 30 to 49 years consult their GP each year with menorrhagia
More informationof AUB DISCLOSURES 10/29/2018
of AUB DR. DEBRA GIERUT MD DEPARTMENT OF OBSTETRICS AND GYNECOLOGY KAISER PERMANENTE, ORANGE COUNTY DISCLOSURES I have no financial disclosures Lisa Samerdyke, the Director of National Accounts for Hologic
More informationUpdate on Medical and Surgical Therapy Sara Jane Pieper, MD Chair, Gynecology Development Team
ABNORMAL UTERINE BLEEDING Update on Medical and Surgical Therapy Sara Jane Pieper, MD Chair, Gynecology Development Team Goals Review appropriate medical therapies for abnormal uterine bleeding Review
More informationHeavy Menstrual Bleeding. Mr Nick Nicholas MD FRCOG Grad Dip Law. Consultant Gynaecologist
Heavy Menstrual Bleeding Mr Nick Nicholas MD FRCOG Grad Dip Law. Consultant Gynaecologist Why is HMB so important? 1:20 women aged 30-49 consult their GP with HMB Once referred to gynaecologist, surgical
More informationPERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.
PERIMENOPAUSE Patricia J. Sulak, MD Founder, Living WELL Aware LLC Author, Should I Fire My Doctor? Author, Living WELL Aware: Eleven Essential Elements to Health and Happiness Endowed Professor Texas
More informationPOTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL. Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist
POTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist THE PILL Released to US market in 1960 10-15 x dose of hormones in HRT Over 10-14
More informationHealthcare Education Research
Healthcare Education Research Heavy menstrual bleeding: investigation, diagnosis & management An update for health professionals Assessment of heavy menstrual bleeding in primary care Dr Amanda Newman
More informationPolycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018
Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Learning Objectives At the conclusion of this lecture, learners should: 1) Know the various diagnostic
More information5/5/2010. Infertility FINANCIAL DISCLOSURE. Infertility Definition. Objectives. Normal Human Fertility. Normal Menstrual Cycle
Infertility FINANCIAL DISCLOSURE I HAVE NO FINANCIAL INTEREST IN ANY OF THE PRODUCTS MENTIONED IN MY PRESENTATION Bryan K. Rone, M.D. University of Kentucky Obstetrics and Gynecology I AM RECEIVING COMPENSATION
More informationManaging Menstrual Disorders
Managing Menstrual Disorders David G. Weismiller, MD, ScM, FAAFP Professor Department of Family Medicine The Brody School of Medicine at East Carolina University Greenville, North Carolina Learning Objectives
More informationWendy Shen, MD, PhD Refresher Course for the Family Physician April 5, 2018 Coralville, Iowa
Wendy Shen, MD, PhD Refresher Course for the Family Physician April 5, 2018 Coralville, Iowa Objectives Distinguish the different types of IUDs Understand the mechanism of action and selection of candidates
More informationDr Mary Birdsall. Fertility Associates Auckland
Dr Mary Birdsall Fertility Associates Auckland Period Problems Mary Birdsall Medical Director Fertility Associates Auckland Period Problems Basic Physiology No Periods Irregular Periods Heavy Periods
More informationMolly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine
Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine Review causes of abnormal uterine bleeding: Adolescent Reproductive
More informationTopics. Periods Menopause & HRT Contraception Vulva problems
Girls stuff Topics Periods Menopause & HRT Contraception Vulva problems Menorrhagia Excessive menstrual loss occurring with regular or irregular cycles Ovulatory Anovulatory Usual blood loss 30-40ml per
More informationDysfunctional Uterine Bleeding
Long term effects of PCOS Dysfunctional Uterine Bleeding Dr. Arulmozhi Ramarajan Church of South India Hospital, Bangalore Abnormal uterine bleeding Affects health-related QOL Causes social embarrasment
More informationPCOS and Obesity DUB is better treated by OCPs
PCOS and Obesity DUB is better treated by OCPs Dr. Ritu Joshi Senior consultant Fortis escorts Hospital, Jaipur Chairperson Family welfare com. FOGSI (20092012) Vice President FOGSI 2014 Introduction One
More informationPerimenopausal DUB. Mary Anne Jamieson, MD Associate Professor, OB/GYN Queen s University Kingston, Ontario
Perimenopausal DUB Mary Anne Jamieson, MD Associate Professor, OB/GYN Queen s University Kingston, Ontario Objectives Clinicians will: Make a confident diagnosis for Perimenopausal DUB (know how/when to
More informationAbnormal uterine bleeding:
Primary Care Women s Health Forum 16th June 2010 Abnormal uterine bleeding: The University Of Birmingham T Justin Clark MD (Hons), MRCOG Consultant Obstetrician and Gynaecologist Birmingham Women s Hospital
More informationApproach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD
Approach to ovulation induction and superovulation in women with a history of infertility Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the
More informationNon-contraceptive Uses of the Levonorgestrel Intrauterine Device Elena Gates, MD http://www.mirena-us.com/pvs1/pri/whatisframe.html Progestin levels with LNG- IUS Lower plasma levels Mirena 150-200 pg/ml
More informationEndometrial line thickness in different conditions.
Endometrial line thickness in different conditions 1 Endometrial thickens in response to Rising estrogen levels during the menstrual cycle and then shedding endometrial at the times of menses 2 The thickens
More information5 Mousa Al-Abbadi. Ola Al-juneidi & Obada Zalat. Ahmad Al-Tarefe
5 Mousa Al-Abbadi Ola Al-juneidi & Obada Zalat Ahmad Al-Tarefe Abnormal Uterine Bleeding (AUB) AUB is a very common scenario or symptom where women complain of menorrhagia (heavy and/or for long periods),
More informationFibroid mapping. Haitham Hamoda MD FRCOG Consultant Gynaecologist, Subspecialist in Reproductive Medicine & Surgery King s College Hospital
Fibroid mapping Haitham Hamoda MD FRCOG Consultant Gynaecologist, Subspecialist in Reproductive Medicine & Surgery King s College Hospital Fibroids Common condition >70% of women by onset of menopause.
More informationFemale Reproductive System. Lesson 10
Female Reproductive System Lesson 10 Learning Goals 1. What are the five hormones involved in the female reproductive system? 2. Understand the four phases of the menstrual cycle. Human Reproductive System
More informationGLOBAL ENDOMETRIAL ABLATION TECHNOLOGY
GLOBAL ENDOMETRIAL ABLATION TECHNOLOGY Training: Part 1 Anatomy and Physiology Female Anatomy Normal Uterus Female Anatomy Normal Uterus Female Anatomy Uterine Positions Abnormal Uterus Retroflexed Normal
More informationReproductive Testing: Less is More G. Wright Bates, Jr., M.D. Professor and Director Reproductive Endocrinology and Infertility Objectives
Reproductive Testing: Less is More G. Wright Bates, Jr., M.D. Professor and Director Reproductive Endocrinology and Infertility Objectives 1. Review definition of infertility and impact of age 2. Stress
More informationSubject Index. Cavaterm, endometrial ablation complications 146, 150 contraindications 152 cost analysis compared with hysterectomy
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Subject Index Abnormal uterine bleeding, see also Adenomyosis, Endometrial cancer, Menorrhagia dilatation and curettage 21, 22, 25 hysteroscopy of premenopausal women anesthesia
More informationUterine-Sparing Treatment Options for Symptomatic Uterine Fibroids
Uterine-Sparing Treatment Options for Symptomatic Uterine Fibroids Developed in collaboration Learning Objective Upon completion, participants should be able to: Review uterine-sparing fibroid therapies
More informationTopic 24: Estrogens and Female Reproductive Drugs
Topic 24: Estrogens and Female Reproductive Drugs I. Contraceptives A. Estrogen-Progestin Contraceptives Note all of these drugs contain one estrogen (listed first) and one progestin Drug to know: ethinyl
More informationArdhanu Kusumanto Oktober Contraception methods for gyne cancer survivors
Ardhanu Kusumanto Oktober 2017 Contraception methods for gyne cancer survivors Background cancer treatment Care of gyn cancer survivor Promotion of sexual, cardiovascular, bone, and brain health management
More informationThe reproductive lifespan
The reproductive lifespan Reproductive potential Ovarian cycles Pregnancy Lactation Male Female Puberty Menopause Age Menstruation is an external indicator of ovarian events controlled by the hypothalamicpituitary
More information9.4 Regulating the Reproductive System
9.4 Regulating the Reproductive System The Reproductive System to unite a single reproductive cell from a female with a single reproductive cell from a male Both male and female reproductive systems include
More informationInfertility DR. RAHUL BEVARA
Infertility DR. RAHUL BEVARA Definitions Infertility is defined as the inability to conceive after one year of unprotected coitus. Affects 10-15% of couples Primary Infertility, that is inability to conceive
More informationPrimary Care Gynaecology Guidelines: HEAVY REGULAR MENSTRUAL BLEEDING
Primary Care Guidelines: HEAVY REGULAR MENSTRUAL BLEEDING
More informationCASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen?
CASE 41 A 19-year-old woman presents to her gynecologist with complaints of not having had a period for 6 months. She reports having normal periods since menarche at age 12. She denies sexual activity,
More informationChapter 14 Reproduction Review Assignment
Date: Mark: _/45 Chapter 14 Reproduction Review Assignment Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Use the diagram above to answer the next question.
More informationAbnormal Uterine Bleeding
Abnormal Uterine Bleeding Randy A. Fink, MD, FACOG Obstetrics & Gynecology A simplified approach for primary care Disclosures I have no relevant disclosures pertaining to this program. Learning Objectives
More informationBIOH122 Human Biological Science 2
BIOH122 Human Biological Science 2 Session 22 Female Reproductive System 2 The Reproductive Cycle Bioscience Department Endeavour College of Natural Health endeavour.edu.au Session Plan o The female reproductive
More informationUltrasound of Uterus and Ovary
1 of 16 5/3/2005 8:34 PM Contents: Ultrasound of Uterus and Ovary Introduction Section 1: The Normal Ovary by Ultrasound Section 2: Ultrasound of Normal Ovarian Follicular Cycles Section 3: Ultrasound
More informationDysmenorrhea. Erin Eppsteiner, M.D. Department of Ob/Gyn The University of Iowa Roy J & Lucille A Carver College of Medicine
Dysmenorrhea Erin Eppsteiner, M.D. Department of Ob/Gyn The University of Iowa Roy J & Lucille A Carver College of Medicine Objectives Be able to recognize primary and secondary dysmenorrhea Be familiar
More informationPalm Beach Obstetrics & Gynecology, PA
Palm Beach Obstetrics & Gynecology, PA 4671 S. Congress Avenue, Lake Worth, FL 33461 561.434.0111 4631 N. Congress Avenue, Suite 102, West Palm Beach, FL 33407 Endometriosis The lining of the uterus is
More informationContraception. Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine
Contraception Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine Disclosures No financial relationships to disclose I have no commercial, financial, research ties to
More informationPolycystic ovarian disease and Endometriosis
Polycystic ovarian disease and Endometriosis Objectives: At the end of this lecture, the student should be able to: Know the clinicopathologic features of endometriosis with special emphasis on: definition,
More informationOverview of Reproductive Endocrinology
Overview of Reproductive Endocrinology I have no conflicts of interest to report. Maria Yialamas, MD Female Hypothalamic--Gonadal Axis 15 4 Hormone Secretion in the Normal Menstrual Cycle LH FSH E2, Progesterone,
More informationManagement of Uterine Myomas
Management of Uterine Myomas Deidre D. Gunn, MD Assistant Professor Division of Reproductive Endocrinology & Infertility February 16, 2018 Disclosures I have no relevant financial relationships to disclose.
More informationThe 6 th Scientific Meeting of the Asia Pacific Menopause Federation
Abnormal uterine bleeding in the perimenopause Perimenopausal menstrual problems are among the most common causes for family practitioner and specialist referral. Often it is due to the hormone changes
More informationChapter 28: REPRODUCTIVE SYSTEM: MALE
Chapter 28: REPRODUCTIVE SYSTEM: MALE I. FUNCTIONAL ANATOMY (Fig. 28.1) A. Testes: glands which produce male gametes, as well as glands producing testosterone 2. Seminiferous tubules (Fig.28.3; 28.5) a.
More informationEstrogens & Antiestrogens
Estrogens & Antiestrogens Menstrual cycle... Changes and hormonal events Natural estrogens: Estadiol >> Estrone > Estriol Ineffective orally Synthesis: From cholesterol ; role of aromatase enzyme in converting
More informationMedical Management of Fibroids Esmya. Dr Paula Briggs Consultant in Sexual and Reproductive Health
Medical Management of Fibroids Esmya Dr Paula Briggs Consultant in Sexual and Reproductive Health Treatment options for Uterine Fibroids ESMYA Selective Uterine Artery Embolisation Fibroid ablation (hysteroscopic
More informationInvestigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle?
Investigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle? Introduction: The menstrual cycle (changes within the uterus) is an approximately 28-day cycle that
More informationOvaries: In Sickness and Health. Mr N Pisal Consultant Gynaecologist The Portland Hospital
Ovaries: In Sickness and Health Mr N Pisal Consultant Gynaecologist The Portland Hospital Topics for discussion How to assess ovarian function? AMH PCOS Ovarian pain Ovarian cysts Ovarian screening Menopause
More informationMANAGEMENT OF REFRACTORY ENDOMETRIOSIS
(339) MANAGEMENT OF REFRACTORY ENDOMETRIOSIS Serdar Bulun, MD JJ Sciarra Professor and Chair Department of Ob/Gyn Northwestern University ENDOMETRIOSIS OCs Teenager: severe dysmenorrhea often starting
More informationENDOMETRIAL ABLATION: TRENDS AND CHALLENGES IN 2017
ENDOMETRIAL ABLATION: TRENDS AND CHALLENGES IN 2017 Philippe Laberge MD FRCSC ACGE Professor Obstetrics and Gynecology Laval University Quebec, Canada Disclosures I have used products or done clinical
More informationMEDICAL POLICY SUBJECT: ENDOMETRIAL ABLATION
MEDICAL POLICY PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationORILISSA (elagolix) oral tablet
ORILISSA (elagolix) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage
More informationEndometrial Cancer Biopsy of the endometrium Evaluation of women of all ages
Endometrial Cancer Biopsy of the endometrium Evaluation of women of all ages Barbara S. Apgar, MD, MS Professor of Family Medicine University of Michigan Health System Ann Arbor, Michigan Cancer of the
More informationInvestigating HMB- an evidence based approach
BSGE Meeting: Contemporary management of heavy menstrual bleeding (HMB) in primary and secondary care: (7 th December 2018, RCOG) Investigating HMB- an evidence based approach T. Justin Clark MB ChB, MD(Hons),
More informationAMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Formerly The American Fertility Society OVULATION DETECTION A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive
More informationInfertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary
Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that
More informationEvidence Based Guideline Intrauterine Ablation or Resection of the Endometrium
Evidence Based Guideline Intrauterine Ablation or Resection of the Endometrium File Name: intrauterine_ablation_or_resection_of_the_endometrium Guideline Number: EBG.OBGYN3030 Origination: 4/1993 Last
More informationINFERTILITY CAUSES. Basic evaluation of the female
INFERTILITY Infertility is the inability to conceive after 12 months of unprotected intercourse. There are multiple causes of infertility and a systematic way to evaluate the condition. Let s look at some
More informationIntroduction to GYN Specialties
Outline Introduction to GYN Specialties Gynecologic Oncology* Female Pelvic Medicine and Reconstructive Surgery* Reproductive Endocrinology and Infertility* Pediatric and Adolescent Gynecology** Family
More informationChapter 27 The Reproductive System. MDufilho
Chapter 27 The Reproductive System 1 Figure 27.19 Events of oogenesis. Before birth Meiotic events 2n Oogonium (stem cell) Mitosis Follicle development in ovary Follicle cells Oocyte 2n Primary oocyte
More informationCenter for Menstrual Disorders, Fibroids and Hysteroscopic Services
Center for Menstrual Disorders, Fibroids and Hysteroscopic Services If you experience heavy periods, there is no need to suffer in silence. And if you ve been told that hysterectomy is your only choice,
More informationBreast Cancer Risk in Patients Using Hormonal Contraception
Breast Cancer Risk in Patients Using Hormonal Contraception Bradley L. Smith, Pharm.D. Smith.bradley1@mayo.edu Pharmacy Ground Rounds Mayo Clinic Rochester April 3 rd, 2018 2017 MFMER slide-1 Presentation
More informationDr. Mojibian. Menopause
Dr. Mojibian Menopause I. Introduction - The term menopause is derived from Greek Meno (months) and pause (cessation). The word means cessation of menstruation. - Cliamacteric which is by dictionary definition
More informationEmbryology Lecture # 4
1 Quick Review: Oogenesis : - Oogonia start appear in the ovary when the age of the fetus 1 is th (5 week). - Then the Oogonia transformed into 1ry Oocyte. - 1ry Oocyte is surrounded by a follicle (cover).
More informationContraception: Common Problems Faced in Office Practice. Jane S. Sillman, MD Brigham and Women s Hospital
Contraception: Common Problems Faced in Office Practice Jane S. Sillman, MD Brigham and Women s Hospital Disclosures I have no conflicts of interest Contraception: Common Problems How to discuss contraception
More informationTRHC.UEMEE Ph P y h si s o i logy l of fmen M str st u r at a i t on i
. TRHCUEMEE Physiology of Menstruation Learning objectives: By the end of this lecture the students should be able to: Define menstruation. List the Characters of normal menstruation Enumerate Components
More informationMonth-Long Hormone Assessment: What goes up must come down. Disclaimer. Aims and Objectives. George Gillson MD PhD
Month-Long Hormone Assessment: What goes up must come down George Gillson MD PhD 1 Disclaimer The information presented in this Webinar is the opinion of Dr. Gillson based on his research and experience.
More informationLEARNING OBJECTIVES. Beyond the Pill: Long Acting Contraception. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy is Common
4:15 5 pm Beyond the Pill: Long Acting Contraceptives and IUDs Presenter Disclosure Information The following relationships exist related to this presentation: Christine L. Curry, MD, PhD: No financial
More informationTable I. Examples of Hormone and Tapering Regimens
Table I. Examples of Hormone and Tapering Regimens Severe AUB Heavy bleeding (soaking through 2 maxi pads an hour, 2 hours in a row) History of heavy menses Hemodynamically un (tachycardia, hypotensive,
More informationLearning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories
Learning Objectives Identify common symptoms of the menopause transition Understand the risks and benefits of hormone replacement therapy (HRT) Be able to choose an appropriate hormone replacement regimen
More informationFERTILITY & TCM. On line course provided by. Taught by Clara Cohen
FERTILITY & TCM On line course provided by Taught by Clara Cohen FERTILITY & TCM FERTILITY AND TCM THE PRACTITIONER S ROLE CAUSES OF INFERTILITY RISK FACTORS OBJECTIVES UNDERSTANDING TESTS Conception in
More informationEndometriosis. A Guide for Patients PATIENT INFORMATION SERIES
Endometriosis A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of the Patient Education Committee and the Publications Committee.
More informationProduct Information. Confidence that lasts
Confidence that lasts What is Mirena? Inhibition of sperm motility and function inside the uterus and the fallopian tubes, preventing fertilization (Videla-Rivero et al. 1987). Section of system Levonorgestrel
More informationPrevention, Diagnosis and Treatment of Gynecologic Cancers
Prevention, Diagnosis and Treatment of Gynecologic Cancers Jubilee Brown MD and Pamela T. Soliman MD, MPH Department of Gynecologic Oncology and Reproductive Medicine University of Texas MD Anderson Cancer
More informationEndometriosis. *Chocolate cyst in the ovary
Endometriosis What is endometriosis? Endometriosis is a common condition in young women. It's chronic, painful, and it often progressively gets worse over the time. *Chocolate cyst in the ovary Normally,
More informationPatient Health Forms
Patient Health Forms All forms MUST be completed and signed prior to seeing the Provider First: M: Last: Email Address: Home Address: Best Phone Number to Reach You: Last 4 of your social security #: Marital
More informationMinimal Access Surgery in Gynaecology
Gynaecology & Fertility Information for GPs August 2014 Minimal Access Surgery in Gynaecology Today, laparoscopy is an alternative technique for carrying out many operations that have traditionally required
More information